Front Street Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Front Street Capital Management's AMGN Position: Q1 2024 in Review
Front Street Capital Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 423 shares — an estimated $122K sold.
Front Street Capital Management first reported a position in AMGN in Q2 2016 and held it in 15 quarters. The position peaked at $332K in Q3 2018. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.
- Front Street Capital Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
- Front Street Capital Management sold 423 Amgen shares in Q1 2024, an estimated $122K.
- Front Street Capital Management first reported a position in Amgen in Q2 2016 and held it in 15 quarters.
- Front Street Capital Management's Amgen position peaked at $332K in Q3 2018.
- 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.
Based on Front Street Capital Management's 13F filing for Q1 2024, filed 14 May 2024.